CORALVILLE — When it comes to admitting how much they smoke or drink, people aren’t always the most truthful.
Welcome to the University of Iowa Research Park, where collaborative opportunities in technology abound.
We offer corporations locating at the Park convenient, sustained access to the extensive, relevant research resources of The University of Iowa.
Here, growing enterprises have access to a state-of-the art business incubator, world-class research facilities and a dynamic faculty of scientists, physicians and engineers at one of the world’s leading public research universities.
News & Announcements
IDx, a privately-held AI diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company’s De Novo request to market IDx-DR, an AI-based diagnostic system for the autonomous detection of diabetic retinopathy, a leading cause of blindness. IDx-DR is the first autonomous, AI-based diagnostic system authorized for commercialization by the FDA.
IDx, a University of Iowa spinout company based in Coralville, has received FDA approval to market IDX-DR, the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.